Hunter Biden, the son of former Vice President Joe Biden, holds a stake in a Chinese surveillance company sanctioned by the U.S. for its alleged involvement in the country’s systematic repression of Uighurs and other Muslim minorities, the Washington Free Beacon reported Wednesday.
The news raises further questions about the Biden family’s controversial business dealings in China and casts doubt on Democratic nominee Joe Biden’s ability to stand up to China on the world stage should he be elected president.
In the report, the Free Beacon noted:
Megvii, known for its core product, Face++, was added to a the U.S. Commerce Department blacklist last year for “human rights violations and abuses in the implementation of China’s campaign of repression, mass arbitrary detention, and high-technology surveillance against Uighurs, Kazakhs, and other members of Muslim minority groups in Xinjiang.”
Hunter Biden’s investment in the company was confirmed as part of a new bombshell documentary on BlazeTV, titled “Riding the Dragon: Uncovering the Bidens’ Chinese Secrets.” The documentary unveils largely unreported details about Hunter Biden’s business ventures in China — which even benefitted the Chinese military — while his father, then the vice president, led U.S. policy efforts in the country.
The film highlights a 2019 report by journalist Lee Fang at The Intercept that details Hunter Biden’s lucrative investment in the company through his private equity firm, Bohai Harvest.
He’s still profiting
The Free Beacon notes that though Biden has since stepped down from the board of the firm, “he still owns a 10 percent stake in the investment firm through his U.S.-based limited liability company Skaneateles LLC, according to corporate records from China’s official company database.”
While Biden has no legal obligation to divest from Megvii, the fact that he may be aiding the persecution of minorities in China by funding technology sanctioned for human-rights abuses is a cause for concern — especially as his father campaigns for president.